Evaluation of a prophylactic transfusion program on obstetric outcomes in pregnant women with sickle cell disease: A single centre retrospective cohort study-Reference-Cited by-同舟云学术

Evaluation of a prophylactic transfusion program on obstetric outcomes in pregnant women with sickle cell disease: A single centre retrospective cohort study

Published:2023-11 Issue: Volume:290 Page:103-108
ISSN:0301-2115
Container-title:European Journal of Obstetrics & Gynecology and Reproductive Biology
language:en
Short-container-title:European Journal of Obstetrics & Gynecology and Reproductive Biology

Author:

Sobczyk O.,Gottardi E.,Lefebvre M.,Canouï-Poitrine F.,Jebali A.,De Luna G.,Pirenne F.,Redel D.,Galacteros F.,Boutin E.,Bartolucci P.,Haddad B.,Habibi A.,Lecarpentier E.^ORCID

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference16 articles.

1. Morbidity associated with sickle cell disease in pregnancy;Villers;Am J Obstet Gynecol,2008

2. Maternal mortality among women with sickle-cell disease in France, 1996–2009;Lesage;Eur J Obstet Gynecol Reprod Biol,2015

3. Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysis;Oteng-Ntim;Blood,2015

4. ACOG Committee on Obstetrics. ACOG Practice Bulletin No. 78: Hemoglobinopathies in pregnancy. Obstet Gynecol 2007;109:229–37.

5. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study;Koshy;N Engl J Med,1988

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylactic red cell transfusions for sickle cell disease pregnancy: increased use of therapy could transform outcomes;Current Opinion in Hematology;2024-08-15

2. Advances in pharmacotherapy for sickle cell disease: what is the current state of play?;Expert Opinion on Pharmacotherapy;2024-07-02

3. Sickle cell disease, pregnancy, and COVID-19 in France: <i>plus ça change</i>;Haematologica;2023-12-07